Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

Shingaki Sumito; Tsukada Nobuhiro; Ishida Tadao; Suzuki Kenshi

首页> 外文期刊>Hematological oncology >Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

【24h】

Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

机译：对复发或难治性多发性骨髓瘤患者的无关捐赠者的霉菌异种造血细胞移植的可行性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2018年第1期|共3页
作者
Shingaki Sumito; Tsukada Nobuhiro; Ishida Tadao; Suzuki Kenshi;
展开▼
作者单位

Department of HematologyJapanese Red Cross Medical CenterTokyo Japan;

Department of HematologyJapanese Red Cross Medical CenterTokyo Japan;

Department of HematologyJapanese Red Cross Medical CenterTokyo Japan;

Department of HematologyJapanese Red Cross Medical CenterTokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma [J] . Shingaki Sumito, Tsukada Nobuhiro, Ishida Tadao, Hematological oncology . 2018,第1期

机译：对复发或难治性多发性骨髓瘤患者的无关捐赠者的霉菌异种造血细胞移植的可行性
2. Induction of platelet refractoriness after myeloablative unrelated allogeneic hematopoietic peripheral blood progenitor cell transplant from HLA-sensitized female donor [J] . Conti Fabiana M., Kondo Andrea T., Bub Carolina, Transfusion: The Journal of the American Association of Blood Banks . 2014,第11期

机译：HLA致敏的女性供体的清髓性不相关异基因造血外周血祖细胞移植后诱导血小板不应性
3. Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma [J] . El-CheikhJ., CrocchioloR., BoherJ.-M., European Journal of Haematology . 2012,第6期

机译：高危多发性骨髓瘤患者降低强度条件的同种异体造血干细胞移植后无关和相关供体之间的可比结果
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation for the Treatment of Patients with Poor-Risk Relapsed or Refractory Multiple Myeloma [O] . George E. Georges, Michael B. Maris, David G. Maloney, -1

机译：非清髓性无关供体造血细胞移植治疗低危复发或难治性多发性骨髓瘤患者
7. Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation to Treat Patients with Poor-Risk, Relapsed, or Refractory Multiple Myeloma [O] . Georges George E., Maris Michael B., Maloney David G., 2007

机译：非清髓性无关供体造血细胞移植治疗低危，复发或难治性多发性骨髓瘤患者

Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

著录项

相似文献

相关主题

期刊订阅